News

All news

2019-08-19

ACCORD HEALTHCARE LAUNCH SOLIFENACIN SUCCINATE

Accord Healthcare is delighted to announce the launch of Solifenacin Succinate 5 mg & 10 mg which are available in a pack size of 30 Film-coated tablets.  

This medicine is indicated for the symptomatic treatment of urge incontinence and /or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.

Please refer to the Summary of Product Characteristics (SPC) for further information. The SPC is available here.

All news